Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism

作者: M P J Vanderpump , J A O Ahlquist , J A Franklyn , R N Clayton

DOI: 10.1136/BMJ.313.7056.539

关键词:

摘要: Thyroid disease is common and may present to a wide range of doctors. With the widespread availability thyroid function testing in recent years increasing numbers patients with symptoms which might be attributable hypothyroidism hyperthyroidism are being tested. Many aspects management have not been subjected controlled clinical trials yet there established practices never questioned. The Research Unit Royal College Physicians London, Endocrinology Diabetes Committee college, Society for set up working group produce consensus statement good practice associated audit measures could used ensure that purchasers health care obtaining an acceptable standard disease. focused on patient rather than presenting signs, were detailed similar report by American Association.1 This summarises views reached members group. Recognised United Kingdom authorities international reputation research as specialists invited background papers specific topic summarised relevant available published evidence from peer reviewed journals (see contributors listed at end this report). Because potential bias development small groups circulated larger before workshop held London. consisted endocrinology, general physicians, surgeons, practitioners, biochemists, representatives groups, report). The …

参考文章(25)
Stephen A. Falk, The management of hyperthyroidism. A surgeon's perspective. Otolaryngologic Clinics of North America. ,vol. 23, pp. 361- 380 ,(1990) , 10.1016/S0030-6665(20)31262-7
Jayne A. Franklyn, Jackie Daykin, Zorka Drolc, Malcolm Farmer, Michael C. Sheppard, Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clinical Endocrinology. ,vol. 34, pp. 71- 76 ,(1991) , 10.1111/J.1365-2265.1991.TB01738.X
Peter A. Singer, Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 808- 812 ,(1995) , 10.1001/JAMA.1995.03520340064038
J. M. McKENZIE, M. ZAKARIJA, Clinical review 3: The clinical use of thyrotropin receptor antibody measurements. The Journal of Clinical Endocrinology and Metabolism. ,vol. 69, pp. 1093- 1096 ,(1989) , 10.1210/JCEM-69-6-1093
Hiroe K. Nakazawa, Kenji Sakurai, Noboru Hamada, Naoko Momotani, Kunihiko Ito, Management of atrial fibrillation in the post-thyrotoxic state. The American Journal of Medicine. ,vol. 72, pp. 903- 906 ,(1982) , 10.1016/0002-9343(82)90850-6
JA Franklyn, Ji Betteridge, J Daykin, GD Oates, JV Parle, DA Heath, MC Sheppard, R Holder, J Lilley, Long-term thyroxine treatment and bone mineral density The Lancet. ,vol. 340, pp. 9- 13 ,(1992) , 10.1016/0140-6736(92)92423-D
H. Y M Fung, M. Kologlu, K. Collison, R John, C J Richards, R Hall, A M McGregor, Postpartum thyroid dysfunction in Mid Glamorgan BMJ. ,vol. 296, pp. 241- 244 ,(1988) , 10.1136/BMJ.296.6617.241
D Reinwein, G Benker, J H Lazarus, W D Alexander, A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. The Journal of Clinical Endocrinology and Metabolism. ,vol. 76, pp. 1516- 1521 ,(1993) , 10.1210/JCEM.76.6.8501160